-+ 0.00%
-+ 0.00%
-+ 0.00%

Medicus Pharma Announces Co-Development And License Agreement With Pfizer For CD228-Targeting ADC PF-08046031, Paying $12M Upfront And $15M In One Year; Pfizer Eligible For Over $1B In Milestones Plus Royalties

Benzinga·09/03/2026 12:47:05
语音播报

https://www.sec.gov/Archives/edgar/data/1997296/000106299326004806/form8k.htm